Abstract:<section class="article-section article-section__abstract" lang="en" data-lang="en" id="section-1-en"> <h3 class="article-section__header main main">Abstract</h3> <div class="article-section__content en main"> <p>Hidradenitis suppurativa (HS)/acne inversa is a debilitating chronic disease that remains poorly understood and difficult to manage. Clinical practice is variable and there is a need for international, evidence‐based and easily applicable consensus on HS management. We report here the findings of a systematic literature review, which were subsequently used as a basis for the development of international consensus recommendations for the management of patients with HS.</p> <p>A systematic literature review was performed for each of nine clinical questions in HS (defined by an expert steering committee), covering comorbidity assessment, therapy (medical, surgical and combinations), and response to treatment. Included articles underwent data extraction and were graded according to the Oxford Centre for Evidence‐based Medicine criteria. Evidence‐based recommendations were then drafted, refined, and voted upon, using a modified Delphi process.</p> <p>Overall, 5,310 articles were screened, 171 articles analyzed, and 65 used to derive recommendations. These articles included six randomized controlled trials plus cohort studies and case series. The highest level of evidence concerned dosing recommendations for topical clindamycin in mild disease (with systemic tetracyclines for more frequent/widespread lesions) and biologic therapy (especially adalimumab) as second‐line agents (following conventional therapy failure). Good‐quality evidence was available for the hidradenitis suppurativa clinical response (HiSCR) as a dichotomous outcome measure in inflammatory areas under treatment. Lower‐level evidence supported recommendations for topical triclosan and oral zinc in mild‐to‐moderate HS, systemic clindamycin and rifampicin in moderate HS and intravenous ertapenem in selected patients with more severe disease. Intralesional or systemic steroids may also be considered. Local surgical excision is suggested for mild‐to‐moderate HS, with wide excision for more extensive disease.</p> <p>Despite a paucity of good quality data on management decisions in HS, this systematic review has enabled the development of robust and easily applicable clinical recommendations for international physicians based on graded evidence.</p> <p>This article is protected by copyright. All rights reserved.</p>

Improving hidradenitis suppurativa patient education using written action plan: a randomized controlled trial

A New Tool to Improve Communication Between Hidradenitis Suppurativa Patients and Health Care Providers

The most recent advances in understanding and managing hidradenitis suppurativa

Integrating primary palliative care into hidradenitis suppurativa management

A centre-based ambulatory care concept for hidradenitis suppurativa improves disease activity, disease burden and patient satisfaction: results from the randomized controlled EsmAiL trial

Improving hidradenitis suppurativa management: consensus statements from physicians and patients' perspectives

Adherence to Hidradenitis Suppurativa Treatment

Data wobbles in hidradenitis suppurativa clinical trials and potential contributing factors: a retrospective review

Ustekinumab with Intravenous Infusion: Results in Hidradenitis Suppurativa

Hidradenitis suppurativa: new insights into disease mechanisms and an evolving treatment landscape

Hidradenitis suppurativa/acne inversa: a practical framework for treatment optimization – systematic review and recommendations from the HS ALLIANCE working group

Real-World Moderate-to-Severe Hidradenitis Suppurativa: Decrease in Disease Burden With Adalimumab

Proof-of-concept study exploring the effect of spesolimab in patients with moderate-to-severe hidradenitis suppurativa: A randomized, double-blind, placebo-controlled clinical trial

Combined Biologic and Surgical Interventions for Hidradenitis Suppurativa: A Systematic Review

Hidradenitis Suppurativa Patient Referrals to a Canadian Community Dermatology Practice: A Retrospective Chart Review

Hidradenitis Suppurativa: Molecular Etiology, Pathophysiology, and Management—A Systematic Review

P091 Surgical management of hidradenitis suppurativa: a 12-month review from a tertiary referral centre on the long-term outcomes of surgical intervention for groin, gluteal, perianal and genital disease

Protocol for the development of a core domain set for hidradenitis suppurativa trial outcomes

Hidradenitis Suppurativa: A Literature Review Comparing Current Therapeutic Modalities

Hidradenitis suppurativa: a new, principle‐centered paradigm for managing a dynamic disease

Identifying Unmet Care Needs and Important Treatment Attributes in the Management of Hidradenitis Suppurativa: A Qualitative Interview Study